Food for thought: A critique on the hypothesis that endogenous cholecystokinin acts as a physiological satiety factor

被引:50
作者
Baldwin, BA
Parrott, RF
Ebenezer, IS [1 ]
机构
[1] Univ Portsmouth, Sch Pharm & Biomed Sci, Neuropharmacol Res Grp, Portsmouth PO1 2DT, Hants, England
[2] Mahidol Univ, Inst Sci & Technol Dev, Neurobehav Biol Ctr, Salaya, Thailand
[3] MAFF, Lab Welfare & Behav, Dept Neurobiol, Babraham Inst, Cambridge CB2 4AT, England
关键词
D O I
10.1016/S0301-0082(98)00005-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This review evaluates the various lines of evidence supporting the hypothesis that cholecystokinin (CCK) released from the small intestine during feeding plays a physiological role in mediating satiety. Issues considered include, the effects of systemic injection of CCK on consummatory and operant Feeding, the role of the vagus nerve, the effects of CCKA and CCKB receptor antagonists, and the neuroendocrine responses to exogenous CCK. A critical appraisal of this research indicates that while it is clearly demonstratable that exogenous peripheral CCK can alter food intake by acting on CCKA receptors, the mechanism involved may be more closely related to the induction of aversion and nausea, rather than satiety. With regard to peripheral endogenous CCK, the available evidence also does not seem to support a role for the hormone in satiety. In particular, it is doubtful whether plasma concentrations of CCK Following a meal are sufficiently high to inhibit feeding. Moreover, CCKA receptor antagonists which do nor cross the blood brain barrier fail to increase meal size, as would be expected if peripheral CCK was an effective satiety factor. In addition, the recent literature concerned with the possibility that CCK may have a direct action within the brain in the control of food intake has been reviewed. These studies show that CCK administered intracerebroventicularly, or by microinjection into discrete brain regions, also inhibits feeding via a CCKA receptor mechanism. However, the physiological relevance of these findings have yet to be determined. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:477 / 507
页数:31
相关论文
共 304 条
[21]   BENZODIAZEPINE GASTRIN AND BRAIN CHOLECYSTOKININ RECEPTOR LIGANDS - L-365,260 [J].
BOCK, MG ;
DIPARDO, RM ;
EVANS, BE ;
RITTLE, KE ;
WHITTER, WL ;
VEBER, DF ;
ANDERSON, PS ;
FREIDINGER, RM .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (01) :13-16
[22]   IONIC MECHANISMS UNDERLYING CHOLECYSTOKININ ACTION IN RAT-BRAIN [J].
BODEN, P ;
WOODRUFF, GN .
CHOLECYSTOKININ, 1994, 713 :129-137
[23]   FOS EXPRESSION IN FERRET DORSAL VAGAL COMPLEX AFTER PERIPHERAL EMETIC STIMULI [J].
BOISSONADE, FM ;
SHARKEY, KA ;
DAVISON, JS .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (04) :R1118-R1126
[24]  
BORISON HL, 1953, PHARMACOL REV, V5, P193
[25]  
BRADWEJN J, 1992, MULTIPLE CHOLECYSTOK, P121
[26]   IDENTIFICATION AND MEASUREMENT OF MOLECULAR VARIANTS OF CHOLECYSTOKININ IN DUODENAL MUCOSA AND PLASMA - DIMINISHED CONCENTRATIONS IN PATIENTS WITH CELIAC-DISEASE [J].
CALAM, J ;
ELLIS, A ;
DOCKRAY, GJ .
JOURNAL OF CLINICAL INVESTIGATION, 1982, 69 (01) :218-225
[27]   EFFECTS OF CHOLECYSTOKININ-OCTAPEPTIDE ON THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS FUNCTION AND ON VASOPRESSIN, PROLACTIN AND GROWTH-HORMONE RELEASE IN HUMANS [J].
CALOGERO, AE ;
NICOLOSI, AMG ;
MONCADA, ML ;
CONIGLIONE, F ;
VICARI, E ;
POLOSA, P ;
DAGATA, R .
NEUROENDOCRINOLOGY, 1993, 58 (01) :71-76
[28]   RESPONSES OF NEURONS OF CANINE AREA POSTREMA TO NEUROTRANSMITTERS AND PEPTIDES [J].
CARPENTER, DO ;
BRIGGS, DB ;
STROMINGER, N .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 1983, 3 (02) :113-126
[29]  
CARPENTER DO, 1982, SAMTR8228 USAF SCH A